CXCL10 and Hepatic fibrosis: A comparative study of IP-10 deficient mice (IP-10−/− and C57BL/6 mice treated with the neutralizing anti-IP-10 antibody) and wildtype C57BL/6 mice showed that CCl4-induced liver fibrosis was less severe in the IP-10 deficient mice with massively increased infiltrating NK cells but lower frequency of activated HSCs37.